BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 16927309)

  • 1. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
    Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
    J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal.
    Javed A; Bae JS; Afzal F; Gutierrez S; Pratap J; Zaidi SK; Lou Y; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    J Biol Chem; 2008 Mar; 283(13):8412-22. PubMed ID: 18204048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
    Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
    J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription.
    Afzal F; Pratap J; Ito K; Ito Y; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Javed A
    J Cell Physiol; 2005 Jul; 204(1):63-72. PubMed ID: 15573378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation.
    Javed A; Afzal F; Bae JS; Gutierrez S; Zaidi K; Pratap J; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cells Tissues Organs; 2009; 189(1-4):133-7. PubMed ID: 18728344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.
    Hassan MQ; Tare RS; Lee SH; Mandeville M; Morasso MI; Javed A; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    J Biol Chem; 2006 Dec; 281(52):40515-26. PubMed ID: 17060321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation.
    Yang S; Wei D; Wang D; Phimphilai M; Krebsbach PH; Franceschi RT
    J Bone Miner Res; 2003 Apr; 18(4):705-15. PubMed ID: 12674331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes.
    Hassan MQ; Tare R; Lee SH; Mandeville M; Weiner B; Montecino M; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2007 May; 27(9):3337-52. PubMed ID: 17325044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
    Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
    J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts.
    Gersbach CA; Guldberg RE; García AJ
    J Cell Biochem; 2007 Apr; 100(5):1324-36. PubMed ID: 17131362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.
    Mbalaviele G; Sheikh S; Stains JP; Salazar VS; Cheng SL; Chen D; Civitelli R
    J Cell Biochem; 2005 Feb; 94(2):403-18. PubMed ID: 15526274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1 represses the transcriptional activity of Runx2 in C2C12 cells.
    Jeong HM; Choi YH; Lee SH; Lee KY
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):103-10. PubMed ID: 24325869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype.
    Banerjee C; Javed A; Choi JY; Green J; Rosen V; van Wijnen AJ; Stein JL; Lian JB; Stein GS
    Endocrinology; 2001 Sep; 142(9):4026-39. PubMed ID: 11517182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein rescues the lack of secondary cartilage in Runx2-deficient mice.
    Fukuoka H; Shibata S; Suda N; Yamashita Y; Komori T
    J Anat; 2007 Jul; 211(1):8-15. PubMed ID: 17555546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
    Guo J; Cooper LF
    Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.